Reliability of anergy skin testing in persons with HIV infection

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1982-1984

  Chin, Daniel P ^f   Osmond, Dennis ^a   Page Shafer, Kim ^g   Glassroth, Jeffrey ^c   Rosen, Mark J ^e   Reichman, Lee B ^d   Kvale, Paul A ^b   Wallace, Jeanne M ^a   Poole, W Kenneth ^g   Hopewell, Philip C ^a   Stansel, John ^a   Turner, Joan ^a   LeMaire, Barbara ^a   Richer, Barbara ^a   Au, Janet ^a   Coulson, Anne ^a   Clemente, Virgilio ^a   Shapiro, Bert ^a   Markowitz, Norman ^b   Saravolatz, Louis D ^b   Johnson, Christine ^b   Huisting, Joanne ^b   Krystoforski, Annmarie ^b   Mossar, Melinda ^c   Hirschtick, Robert ^c   Mangura, Bonita T ^d   Barnes, Saundra ^d   Meilselman, Lori ^e   Manghisi, Kim K ^e   Scheider, Roselyn F ^e   Cardoso, Christopher ^e   Kalb, Thomas H ^e   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f SAN FRANCISCO GENERAL HOSPITAL   (United States)

^g San Francisco General Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIGEN RECOGNITION; ARTICLE; CLONAL ANERGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN ALLERGY; SKIN TEST;

EID: 8944221187     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665065     Document Type: Article

References (9)

1. Centers for Disease Control. 1991. Purified protein derivative (PPD)-tuberculin anergy and HIV infection. M.M.W.R. 40:27-33.
2. Redfield, R., D. Wright, and E. Tramont. 1986. The Walter Reed staging classification for HTLV-III/LAV infection. N. Engl. J. Med. 314: 131-132.
3. Selwyn, P., B. Sckell, P. Alcabes, G. Friedland, R. Klein, and E. Schoenbaum. 1992. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. J.A.M.A. 268:504-509.
4. Moreno, S., J. Baraia-Etxaburu, E. Bouza, F. Parras, M. Perez-Tascon, P. Miralles, T. Vicente, J. Alberdi, J. Cosin, and D. Lopez-Gay. 1993. Risk for developing tuberculosis among anergic patients infected with HIV. Ann. Intern. Med. 119:194-198.
5. Guelar, A., J. Gatell, J. Verdejo, D. Podzamczer, L. Lozano, E. Aznar, J. Miro, J. Mallolas, L. Zamora, J. Gonzalez, and E. Soriano. 1993. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 7:1345-1349.
6. Pulmonary Complications of HIV Infection Study Group. 1993. The prospective study of pulmonary complications of human immunodeficiency virus infection. J. Clin. Epidemiol. 46:497-507.
7. Markowitz, N., N. Hansen, T. Wilcosky, P. Hopewell, J. Glassroth, P. Kvale, B. Mangura, D. Osmond, J. Wallace, M. Rosen, and L. Riechman, for the Pulmonary Complications of HIV Infection Study Group. 1993. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann. Intern. Med. 119:185-193.
8. Paesanti, E. 1994. The negative tuberculin test: tuberculin, HIV and anergy panels. Am. J. Respir. Crit. Care Med. 149:1699-1709.
9. Selwyn, P., D. Hartel, V. Lewis, E. Schoenbaum, S. Vermund, R. Klein, A. Walker, and G. Friedland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with HIV infection. N. Engl. J. Med. 320:545-550.